Cases & Deals

Alizé Pharma SAS acquired by Millendo Therapeutics, Inc.

Clients Alizé Pharma SAS

Jones Day advised Alizé Pharma SAS, a French clinical-stage biotech private company, in connection with its sale in a stock-for-stock transaction to Millendo Therapeutics, Inc., a U.S. clinical-stage biotech private company focused on developing novel treatments for endocrine diseases.